Abbas Ardehali active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOM'UP | Director/Board Member | 29/01/2018 | - |
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Director/Board Member | 31/05/2023 | - |
Career history of Abbas Ardehali
Training of Abbas Ardehali
| Emory University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 3 |
| France | 2 |
Operational
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
- Stock Market
- Insiders
- Abbas Ardehali
- Experience